Literature DB >> 21427603

The history of radical hysterectomy.

Polat Dursun1, Murat Gultekin, Ali Ayhan.   

Abstract

Carcinoma of the uterine cervix provides one of the few examples in medical history of a method of treatment that was once discarded by most of the medical profession and was later reclaimed. In addition, radical hysterectomy (RH) competed with radical vaginal hysterectomy during the early history of RH. The primitive form of RH was first described by Clark and Reis in 1895. Radical hysterectomy was then described in detail and performed by Wertheim, more than 100 years ago. Afterward, RH was abandoned for the treatment of carcinomas because of the use of radiotherapy; however, RH was then modified and repopularized by Meigs in the 1950s. The surgical principles of this operation have undergone only minor modifications throughout the years and remained the basis of the surgical approach used by gynecologic oncologists today. The history of the treatment of cervical carcinoma and the history of RH are unique in medicine. Because of the efforts of the surgeons and scientists, cervical carcinoma has become rarer, and its mortality rate has decreased, although it is still common in undeveloped countries. The history of the treatment of cervical carcinoma includes 3 Nobel Prize winners and 1 Nobel Prize nominee. We therefore think that knowledge of the historical development of this filed will inspire and contribute to the education of future generations. In this article, the historical development of the surgical treatment of cervical carcinoma, the contributors to this surgical procedure, and the pioneers of the surgical and medical treatment of cervical carcinoma are summarized; pictures and illustrations are also provided. Our aim was to inform the gynecologic oncology community about the pioneers that devoted their professional lives to develop of these techniques.

Entities:  

Mesh:

Year:  2011        PMID: 21427603     DOI: 10.1097/LGT.0b013e31820eb038

Source DB:  PubMed          Journal:  J Low Genit Tract Dis        ISSN: 1089-2591            Impact factor:   1.925


  8 in total

1.  Incidence of pelvic organ prolapse repair subsequent to hysterectomy: a comparison between radical hysterectomy and total abdominal hysterectomy.

Authors:  Rune Lykke; Jan Blaakær; Bent Ottesen; Helga Gimbel
Journal:  Int Urogynecol J       Date:  2016-10-17       Impact factor: 2.894

2.  Case report of laparoscopic reduction of retro-ureter incarcerated small bowel obstruction.

Authors:  Sungwoo Cho; Sangchul Yun; Yunhee Lee; Myong Hoon Ihn
Journal:  Medicine (Baltimore)       Date:  2019-12       Impact factor: 1.889

Review 3.  Management of Early-Stage Cervical Cancer: A Literature Review.

Authors:  Yasmin Medeiros Guimarães; Luani Rezende Godoy; Adhemar Longatto-Filho; Ricardo Dos Reis
Journal:  Cancers (Basel)       Date:  2022-01-24       Impact factor: 6.639

4.  The Landmark Series: Minimally Invasive Surgery for Cervical Cancer.

Authors:  Derman Basaran; Mario M Leitao
Journal:  Ann Surg Oncol       Date:  2020-10-30       Impact factor: 5.344

Review 5.  Cervical Cancer Surgery: Current State of Affairs.

Authors:  Fan Chun Yang; Wei Huang; Weihong Yang; Jie Liu; Guihai Ai; Ning Luo; Jing Guo; Peng Teng Chua; Zhongping Cheng
Journal:  Gynecol Minim Invasive Ther       Date:  2021-04-30

6.  Prognostic and Safety Roles in Laparoscopic Versus Abdominal Radical Hysterectomy in Cervical Cancer: A Meta-analysis.

Authors:  Tiefeng Cao; Yanling Feng; Qidan Huang; Ting Wan; Jihong Liu
Journal:  J Laparoendosc Adv Surg Tech A       Date:  2015-11-19       Impact factor: 1.878

7.  Jejunal torsion around the right ureter presenting as postoperative bowel obstruction: a case report.

Authors:  HuseyinYuce Bircan; Bora Koc; Umit Ozcelik; Alp Demirag
Journal:  J Med Case Rep       Date:  2014-06-19

8.  Comparative Effectiveness of Abdominal versus Laparoscopic Radical Hysterectomy for Cervical Cancer in the Postdissemination Era.

Authors:  Jin Hee Kim; Kyungjoo Kim; Seo Jin Park; Jung-Yun Lee; Kidong Kim; Myong Cheol Lim; Jae Weon Kim
Journal:  Cancer Res Treat       Date:  2018-09-11       Impact factor: 4.679

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.